[Retracted] The Valuable Role of ARMC1 in Invasive Breast Cancer as a Novel Biomarker

Table 1

Clinicopathological characteristics of BRCA samples.

	No. (%)
Location
Left site	443 (51)
Right site	419 (48.2)
Unknown	7 (0.8)
Histology
Ductal carcinoma	608 (70)
Lobular carcinoma	215 (24.7)
Other types of carcinoma	45 (5.2)
Unknown	1 (0.1)
Nathologic tumor stage
Stage I	156 (18)
Stage II	498 (57.3)
Stage III	189 (21.7)
Stage IV	12 (1.4)
Unknown	14 (1.6)
Nodal status
N+	442 (50.9)
N-	408 (47)
Unknown	19 (2.1)
Nodal status, nr. of +
0	367 (42.2)
1-3	249 (28.6)
4-9	85 (9.8)
≥10	50 (5.8)
Unknown	118 (13.6)
Lymphovascular invasion
Present	442 (50.9)
Absent	408 (47)
Unknown	19 (2.1)
T stage
T1	240 (27.6)
T2	493 (56.7)
T3	98 (11.3)
T4	28 (3.2)
Unknown	10 (1.2)
N stage
N0	408 (46.9)
N1	296 (34.1)
N2	88 (10.1)
N3	58 (6.7)
Unknown	19 (2.2)

N+: lymph node positive; N-: lymph node negative; BRCA: invasive breast carcinoma.